Tinea Pedis

• FDA approval · 2015-07-15
  FDA Approved: ECONAZOLE NITRATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

  FDA approved a supplemental application for econazole nitrate from Sun Pharmaceutical Industries, Inc., resulting in an approved update rela…

• FDA approval · 2015-03-03
  FDA Approved: OXISTAT — Supplemental Application (ANI Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for OXISTAT (oxiconazole nitrate) submitted by ANI Pharmaceuticals. The update modifies the labe…

• FDA approval · 2015-01-05
  FDA Approved: CLOTRIMAZOLE — Supplemental Application (Rite Aid Corporation)

  FDA approved a supplemental application for clotrimazole submitted by Rite Aid Corporation, indicating an updated/expanded approval for this…

• FDA approval · 2014-12-01
  FDA Approved: CICLOPIROX — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved a supplemental application for Ciclopirox from Glenmark Pharmaceuticals Inc., USA.

• FDA approval · 2014-11-24
  FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)

  The FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) by Voyant Beauty Inc., indicating regulatory cl…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2014-10-10
  FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)

  FDA approved a supplemental application for NAFTIN (naftifine hydrochloride) from Legacy Pharma USA Inc.

• FDA approval · 2014-09-24
  FDA Approved: NAFTIN — Supplemental Application (Legacy Pharma USA Inc.)

  FDA approves a supplemental application for Naftin (naftifine hydrochloride) by Legacy Pharma USA Inc., resulting in labeling updates throug…

• FDA approval · 2013-11-14
  FDA Approved: LUZU — Original Application (Bausch Health US, LLC)

  FDA approved LUZU (luliconazole) as a topical antifungal for the treatment of superficial fungal infections of the skin caused by dermatophy…

• FDA approval · 2013-11-13
  FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)

  The FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc.

• FDA approval · 2013-06-27
  FDA Approved: NAFTIN — Original Application (Legacy Pharma USA Inc.)

  FDA approved NAFTIN (naftifine hydrochloride) under an Original Application from Legacy Pharma USA Inc. for topical treatment of dermatophyt…

• FDA approval · 2013-05-21
  FDA Approved: CICLOPIROX OLAMINE — Supplemental Application (Cosette Pharmaceuticals, Inc.)

  FDA approved a supplemental application for Ciclopirox Olamine from Cosette Pharmaceuticals, resulting in updated labeling for its topical a…

• FDA approval · 2013-02-05
  FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)

  The FDA approved a supplemental application for terbinafine hydrochloride products from NorthStar Rx LLC. This action confirms continued ava…

• FDA approval · 2013-01-03
  FDA Approved: KETOCONAZOLE — Supplemental Application (THIRTY MADISON INC)

  FDA approves a supplemental application for ketoconazole submitted by Thirty Madison Inc (ANDA076942).

• FDA approval · 2012-10-22
  FDA Approved: ULTRAMICROSIZE GRISEOFULVIN — Original Application (Sigmapharm Laboratories, LLC)

  FDA approved the original application (ANDA) for ULTRAMICROSIZE GRISEOFULVIN from Sigmapharm Laboratories, LLC.

• FDA approval · 2012-05-02
  FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)

  FDA approved a supplemental application for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) from Bayer, updating the product’s appro…

• FDA approval · 2012-04-10
  FDA Approved: TERBINAFINE HYDROCHLORIDE — Supplemental Application (Breckenridge Pharmaceutical, Inc.)

  FDA approves Breckenridge Pharmaceutical's supplemental application for terbinafine hydrochloride, a generic antifungal, to market an additi…

• FDA approval · 2012-03-20
  FDA Approved: LAMISIL AT CREAM — Supplemental Application (Voyant Beauty Inc.)

  FDA approved a supplemental application for LAMISIL AT CREAM (terbinafine hydrochloride) with Voyant Beauty as the manufacturer.

• FDA approval · 2012-03-20
  FDA Approved: LAMISIL AT — Supplemental Application (Karo Healthcare Inc.)

  FDA approved a supplemental application for LAMISIL AT (terbinafine hydrochloride) submitted by Karo Healthcare Inc., representing an additi…

• FDA approval · 2012-02-29
  FDA Approved: CICLOPIROX — Original Application (Glenmark Pharmaceuticals Inc., USA)

  FDA approved Glenmark's ciclopirox as a generic product under an original ANDA application.

• FDA approval · 2011-09-21
  FDA Approved: TERBINAFINE — Supplemental Application (NorthStar Rx LLC)

  FDA approved a supplemental application for Terbinafine hydrochloride from NorthStar Rx LLC, updating the generic product's approval.

• FDA approval · 2011-03-31
  FDA Approved: LOTRIMIN ULTRA ATHLETES FOOT — Supplemental Application (Bayer Healthcare LLC.)

  FDA approved a supplemental application for Lotrimin Ultra Athletes Foot (butenafine hydrochloride) by Bayer Healthcare LLC.

• FDA approval · 2011-02-23
  FDA Approved: CICLOPIROX — Original Application (Sun Pharmaceutical Industries, Inc.)

  The FDA approved Sun Pharmaceutical's Ciclopirox as an original ANDA, authorizing the generic topical antifungal product.

• FDA approval · 2011-02-04
  FDA Approved: KETOCONAZOLE — Supplemental Application (Northstar Rx LLC)

  The FDA approved a supplemental application for Ketoconazole submitted by Northstar Rx LLC.

• FDA approval · 2010-12-20
  FDA Approved: CICLOPIROX OLAMINE — Original Application (Cosette Pharmaceuticals, Inc.)

  FDA approves the original ANDA for Ciclopirox Olamine topical product from Cosette Pharmaceuticals, a generic antifungal treatment. The prod…

• FDA approval · 2010-09-17
  FDA Approved: NIZORAL — Supplemental Application (Kramer Laboratories)

  FDA approved a supplemental application for NIZORAL (ketoconazole) from Kramer Laboratories, resulting in labeling updates for the product.